BCAT1 is commonly up-regulated in many different cancer lines, such as human glioblastoma, breast cancer, and non-small cell lung carcinoma (NSCLC), while BCAT2 seems more important for pancreatic cancer [180]. Here, BCAT1 is linked to non-small cell lung carcinoma.